On 14 January 2025, the European Medicines Agency (EMA) confirmed that Alzheimer Europe continues to com-ply with its strict eligibility criteria, as defined by its Man-agement Board, and can continue to be involved in its ac-tivities. The list of all the patients' and consumers' organisa-tions that are involved in EMA activities can be viewed here: https://www.ema.europa.eu/en/partners-networks/patients-consumers/eligible-patients-consumers-organisations
